Category: 1.1b
-
Israeli co Dream Security raises $100m at $1.1b valuation
•
Israeli cybersecurity company Dream securityThe former company NSO Group, CEO of the former Speware Company, Shalaf Holly, former Austrian adviser Sebastian Corse and Jill Dolph, raised $ 100 million in the evaluation of the company of $ 1.1 billion. The emerging company sells Internet protection systems to complex or old…
-
Best Altcoins to Buy as $1.1B Superbowl Polymarket Shows Crypto Hype Is Skyrocketing
•
The online prediction market has seen Polymarket, where users can bet with Crypto, $ 1.1 billion in Superbowl Bets yesterday. One person got a profit of $ 550,000, while another lost 718 thousand dollars. Polymark explains that Crypto flows to the fans that they can use for anything, including betting…
-
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand (NASDAQ:CDMO)
•
Maxim Labkowski AVID Vital Services (Nasdaq: CDMO) to be acquired through funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal valuing the company at approximately $1.1 billion. Under the deal, GHO and Ampersand will acquire all of Avid’s (CDMO) outstanding shares for $12.50 per share…
-
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand (NASDAQ:CDMO)
•
Maxim Labkowski AVID Vital Services (Nasdaq: CDMO) to be acquired through funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal valuing the company at approximately $1.1 billion. Under the deal, GHO and Ampersand will acquire all of Avid’s (CDMO) outstanding shares for $12.50 per share…
-
Alcoa to sell its 25.1% stake in Ma’aden JV for $1.1B (NYSE:AA)
•
JHVEPHOTO/Istock is an editorial via Getty Images Alcoa (New York:AASaudi Electricity Company said on Sunday that it has entered into a binding agreement to purchase shares and subscribe with Saudi Arabian Mining Company (“Maaden”). Under the agreement, Saudi Aramco will sell its entire 25.1% stake in the Maaden joint venture…
-
Agios to receive $1.1B in milestone payments for vorasidenib approval (NASDAQ:AGIO)
•
study Agios PharmaceuticalsNASDAQ: AGIWAmerican drugmaker ABM said it will receive $1.1 billion in milestone payments after the U.S. Food and Drug Administration approved its drug furasidinib to treat malignant brain tumors. The biotech company said it will receive $905 million from Royalty Pharma in connection with its recent royalty agreement.…
-
Israel spent $1.1b on nuclear weapons in 2023 – report
•
The International Campaign to Abolish Nuclear Weapons ranked Israel seventh in terms of investment in nuclear weapons last year. The International Campaign to Abolish Nuclear Weapons estimates that Israel spent about $1.1 billion on nuclear weapons in 2023. The International Campaign to Abolish Nuclear Weapons was awarded the Nobel Peace…